메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Now Available: JSAUX Split EveryDay Case for Switch 2

Designed for daily convenience, the new series offers three modular configurations to match any lifestyle. HONG KONG, Jan. 29, 2026 -- JSAUX, a leading gaming hardware brand, today announced the official launch of the Split EveryDay Case for Nintendo Switch 2. Designed to strike the perfect balance between portability and reliable protection, this new lineup provides a lightweight solution that seamlessly integrates into the daily lives of Switch 2 users. Versatile Options for Every Scenario The core innovation of the "Split EveryDay Case for Switch 2" l
- 김장윤(JASON KIM) 기자
- 2026-01-29 22:00
LEIFRAS Co., Ltd. Awarded Contract to Manage Community-Based Club Activities at Monbetsu Municipal Junior High Schools in Hokkaido

[ 메디채널 황정호 기자 ] Supporting the Shift of Club Activity Management from Schools to Local Communities Through the "Monbetsu Model" TOKYO, Jan. 29, 2026 -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engagement, announced today that it has been awarded a contract by Monbetsu City, Hokkaido to provide community-based club activity management and operation services (the "Contract"). Pursuant to the Contract, the Company will operate and manage a comm
- 황정호 기자
- 2026-01-29 22:00
Cheche Group Announces Strategic Cooperation with Volkswagen DSSO and Cardif Airstar Insurance to Build Digital Insurance System with Intelligent Pricing Model

BEIJING, Jan. 29, 2026 -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced that Volkswagen (Anhui) Digital Sales and Services Co., Ltd. ("DSSO"), Beijing Cardif Airstar Property & Casualty Insurance Co., Ltd. ("Cardif Airstar Insurance"), and Cheche Group Inc. held a strategic cooperation signing ceremony on January 29, 2026. They will collaborate to develop digital insurance services for Volkswagen owners and expand into areas such as intelligent pricing, intelligent‑dr
- 김장윤(JASON KIM) 기자
- 2026-01-29 21:30
Saudi Arabia Unveils Ambitious New Privatization Strategy to Expand Public-Private Partnerships

[ 메디채널 황정호 기자 ] Strategy sets out 220+ new public-private partnerships contracts by 2030 Targets initial $64 billion (SAR 240 billion) in direct capex investment Broadens private sector participation across new and existing projects National Privatization Strategy accelerates realization of Saudi Vision 2030 economic diversification goals RIYADH, Saudi Arabia, Jan. 29, 2026 -- The Kingdom of Saudi Arabia has launched a new National Privatization Strategy to significantly expand the role of public-private partnerships (PPPs) in delivering and operating large-scale projects an
- 황정호 기자
- 2026-01-29 21:12
MicuRx Announces FDA Clearance of IND Application to Proceed to Phase 2a Trial of MRX-5 in Patients with Mycobacterium abscessus Pulmonary Disease

FOSTER CITY, Calif., Jan. 29, 2026 -- MicuRx Pharmaceuticals, Inc. ("MicuRx"), a clinical-stage biopharmaceutical company focused on developing novel anti-infective therapies for drug-resistant bacterial infections, recently announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for MRX-5, enabling the company to initiate a Phase 2a clinical trial in patients with Mycobacterium abscessus pulmonary disease. M. abscessus pulmonary disease is a serious and prevalent non-tuberculous mycobacterial (NTM) infection assoc
- 김갑성 기자
- 2026-01-29 21:02
XtalPi Convenes Global Experts to Shape the Future of Molecular Glue Drug Discovery: From Serendipity to Precision

Global thought leaders presented cutting-edge research at the 2026 International Symposium on Molecular Glue Drug Discovery. XtalPi unveils the AI-driven XGlue™ platform to enable rapid, closed-loop molecular glue drug discovery. Cross-sector discussions emphasized the need for bridging gaps between academic research, industrial development, and clinical applications. SHANGHAI, Jan. 29, 2026 -- Recently, XtalPi, a global leader in AI- and robotics-powered drug discovery, successfully concluded its 2026 International Symposium on Molecular Glue Drug Discovery. The event
- 김갑성 기자
- 2026-01-29 21:00
Spectrum Dynamics Medical Receives FDA 510(k) Clearance for Veritas.AI™, Its AI-Powered Noise Reduction Platform for VERITON-CT

SARASOTA, Fla., Jan. 29, 2026 -- Spectrum Dynamics Medical, a global leader in digital nuclear medicine imaging solutions, today announced that it has received FDA 510(k) clearance for Veritas.AI™ Noise Reduction, its advanced artificial intelligence platform designed to significantly enhance image quality, diagnostic confidence, and operational efficiency on the VERITON-CT® digital SPECT/CT system. Veritas.AI represents a major advancement in molecular imaging, leveraging a deep learning convolutional neural network (CNN) to intelligently reduce image noise while preservin
- 김갑성 기자
- 2026-01-29 21:00
뉴턴 시네마 제작 영화 마일라, 제55회 로테르담 국제영화제 월드 프리미어 발표

로테르담, 네덜란드, 2026년 1월 29일 -- 뉴턴 시네마(Newton Cinema)가 로테르담 국제영화제(International Film Festival Rotterdam, IFFR)의 브라이트 퓨처(Bright Future) 부문에 자사의 장편 영화 마일라(Mayilaa)가 공식적으로 선정됐다고 밝혔다. 이번 선정은 전 세계의 새로운 영화적 목소리를 발굴하는 데 중점을 둔 IFFR의 취지를 반영한다. Mayilaa — A Newton Cinema Production — Announces World Premiere at the 55th International Film Festival Rotterdam (IFFR) 세말라르 안남(Semmlar Annam) 감독이 연출한 마일라는 일하는 여성들의 삶과 경험을 중심으로, 그들이 마주하는 현실과 시선을 담담하고도 선명하게 그려낸 작품이다. 영화를 선보인 파. 란지트(Pa. Ranjith) 감독은 "'마일라'는 일하는 여성들의 현실과 내면 세계를 포착한 작품이다. 세말라르 안남 감독은 솔직한 영화적 언어로 여성의 세계를 자연스럽고 섬세하게 표현했다.
- 김장윤(JASON KIM) 기자
- 2026-01-29 20:16
Hope Rising in Hainan: International NUT Carcinoma Center Launches in Boao

BOAO, China, Jan. 29, 2026 -- The International NUT Carcinoma Diagnosis and Treatment Center has been inaugurated at Boao International Hospital. Established through a collaboration between Boao International Hospital and Chongqing University Three Gorges Hospital, this center tackles the profound challenges of NUT carcinoma, a rare cancer known for diagnostic difficulty, limited treatments, and poor survival. The center is powered by a landmark Chinese breakthrough: NHWD-870, a novel, oral BET inhibitor, developed by biotech Zhejiang Wenda Pharma Technology Co., Ltd. Clinical data is promisi
- 김갑성 기자
- 2026-01-29 20:00
HCLTech社およびGuardian社提携し、AI駆動テクノロジー変革の過程を加速

ニューヨークとノイダ、インド、, 2026年1月29日 -- HCLTech社（NSE: HCLTECH.NS）（BSE: HCLTECH.BO）は世界的な最大手テクノロジー企業で、米国最大級の生命保険会社と従業員福利厚生の大手プロバイダーであるThe Guardian Life Insurance Company of America®社（Guardian）に選ばれ、Guardian社のAI駆動テクノロジー変革の過程を加速させてシームレスな顧客体験をもたらします。複数年にわたるパートナーシップはGuardian社における長期的なテクノロジー近代化への幅広い転換を反映し、AI主導の変革と合理化されたIT業務に重点を置いています。パートナーシップの一環として、Guardian社はHCLTech社の生成AIサービス変革プラットフォームであるAI Forceを活用し、継続的な企業全体の技術イノベーションを支援します。このパートナーシップによってGuardian社は業務効率を高め、エンジニアリング成果を向上させ、アプリケーション開発、サポート、テスト、インフラ管理における市場投入までの時間を短縮します。「HCLTech社とのパートナーシップはデータとAIを活用し、1社の戦略的パートナーとサービスを統合し、中核テクノロジーの基盤を
- 황정호 기자
- 2026-01-29 19:04

이전

81 82 83 84 85 86 87 88 89 90

많이 본 기사

최근기사

2026-03-03_TUE

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 03시 40분